Rational design of novel diketoacid-containing ferrocene inhibitors of HIV-1 integrase

Bioorg Chem. 2005 Aug;33(4):274-84. doi: 10.1016/j.bioorg.2005.03.001. Epub 2005 Apr 19.

Abstract

Molecular interaction field, density functional, and docking studies of novel potential ferrocene inhibitors of HIV-1 integrase (IN) are reported. The high docking scores, analysis of the ligand-receptor interactions in the active site as well as the molecular interaction potential calculations at the binding site of the receptor indicate important features for novel HIV-1 IN inhibitors. We also confirm in this work a novel binding trench in HIV-1 integrase, recently reported in a theoretical work by other authors. This observation may be interesting since the lack of detailed structural information about IN-ligand interactions has hampered the design of IN inhibitors. Our proposed ligands are open to experimental synthesis and testing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acids / chemistry
  • Binding Sites
  • Drug Design*
  • Ferrous Compounds / chemistry*
  • HIV Integrase / chemistry
  • HIV Integrase / metabolism*
  • HIV Integrase Inhibitors / chemistry*
  • HIV Integrase Inhibitors / pharmacology*
  • Hydrophobic and Hydrophilic Interactions
  • Ligands
  • Metallocenes
  • Models, Molecular
  • Protein Structure, Tertiary

Substances

  • Acids
  • Ferrous Compounds
  • HIV Integrase Inhibitors
  • Ligands
  • Metallocenes
  • HIV Integrase
  • ferrocene